Published in Eur J Cardiothorac Surg on July 01, 2001
Silk-based electrospun tubular scaffolds for tissue-engineered vascular grafts. J Biomater Sci Polym Ed (2008) 1.55
Implantable arterial grafts from human fibroblasts and fibrin using a multi-graft pulsed flow-stretch bioreactor with noninvasive strength monitoring. Biomaterials (2010) 1.51
Small-diameter blood vessels engineered with bone marrow-derived cells. Ann Surg (2005) 1.43
Fabrication of cell microintegrated blood vessel constructs through electrohydrodynamic atomization. Biomaterials (2007) 1.34
Synthesis, characterization and cytocompatibility of polyurethaneurea elastomers with designed elastase sensitivity. Biomacromolecules (2005) 1.26
Biodegradable elastomeric scaffolds with basic fibroblast growth factor release. J Control Release (2007) 1.21
Cellular and molecular regulation of spiral artery remodelling: lessons from the cardiovascular field. Placenta (2010) 1.09
Dynamic culture conditions to generate silk-based tissue-engineered vascular grafts. Biomaterials (2009) 1.06
Effect of strain magnitude on the tissue properties of engineered cardiovascular constructs. Ann Biomed Eng (2007) 0.99
Crosslinked urethane doped polyester biphasic scaffolds: Potential for in vivo vascular tissue engineering. J Biomed Mater Res A (2010) 0.93
Elastase-sensitive elastomeric scaffolds with variable anisotropy for soft tissue engineering. Pharm Res (2008) 0.86
The influence of early-phase remodeling events on the biomechanical properties of engineered vascular tissues. J Vasc Surg (2011) 0.84
Decellularized ureter for tissue-engineered small-caliber vascular graft. J Artif Organs (2008) 0.84
The "artificial artery" as in vitro perfusion model. PLoS One (2013) 0.82
Tissue-engineered graft constructed by self-derived cells and heterogeneous acellular matrix. J Zhejiang Univ Sci B (2006) 0.80
Microvascular engineering in perfusion culture: immunohistochemistry and CLSM findings. Head Face Med (2006) 0.80
Scaffold-free, Human Mesenchymal Stem Cell-Based Tissue Engineered Blood Vessels. Sci Rep (2015) 0.80
Quantifying light scattering with single-mode fiber -optic confocal microscopy. BMC Med Imaging (2009) 0.79
In Vitro Study of Directly Bioprinted Perfusable Vasculature Conduits. Biomater Sci (2015) 0.79
Vascular organogenesis: dream or reality? Organogenesis (2011) 0.79
Development of a novel pulsatile bioreactor for tissue culture. J Artif Organs (2007) 0.79
Effect of multiwall carbon nanotube reinforcement on coaxially extruded cellular vascular conduits. Mater Sci Eng C Mater Biol Appl (2014) 0.78
Shear stress and circumferential stretch by pulsatile flow direct vascular endothelial lineage commitment of mesenchymal stem cells in engineered blood vessels. J Mater Sci Mater Med (2016) 0.77
Intima/medulla reconstruction and vascular contraction-relaxation recovery for acellular small diameter vessels prepared by hyperosmotic electrolyte solution treatment. J Artif Organs (2014) 0.76
Scaffolds in vascular regeneration: current status. Vasc Health Risk Manag (2015) 0.76
Effect of biomimetic conditions on mechanical and structural integrity of PGA/P4HB and electrospun PCL scaffolds. J Mater Sci Mater Med (2007) 0.76
Development and evaluation of elastomeric hollow fiber membranes as small diameter vascular graft substitutes. Mater Sci Eng C Mater Biol Appl (2015) 0.75
Cyclic Stretch and Perfusion Bioreactor for Conditioning Large Diameter Engineered Tissue Tubes. Ann Biomed Eng (2015) 0.75
A Tubular Biomaterial Construct Exhibiting a Negative Poisson's Ratio. PLoS One (2016) 0.75
Fabrication of tissue-engineered vascular grafts with stem cells and stem cell-derived vascular cells. Expert Opin Biol Ther (2015) 0.75
Surgical treatment of acquired left ventricular pseudoaneurysms. Ann Thorac Surg (2000) 2.23
Normothermia versus hypothermia during cardiopulmonary bypass: a randomized, controlled trial. Ann Thorac Surg (1995) 1.89
Functional living trileaflet heart valves grown in vitro. Circulation (2000) 1.77
Laser to the heart: magic but costly, or only costly? Lancet (1999) 1.71
Joint statement on redundant (duplicate) publication by the editors of the undersigned cardiothoracic journals. Ann Thorac Surg (2000) 1.64
Embolization of biologic glue during repair of aortic dissection. Ann Thorac Surg (1995) 1.52
Causes of death after the modified Norwood procedure: a study of 122 postmortem cases. Ann Thorac Surg (1997) 1.49
Improved distal circulatory support for repair of descending thoracic aortic aneurysms. Ann Thorac Surg (1993) 1.49
Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur J Cardiothorac Surg (2000) 1.45
Outcome of cardiovascular surgery and pregnancy: a systematic review of the period 1984-1996. Am J Obstet Gynecol (1998) 1.45
Postoperative course of S-100B protein and neuron-specific enolase in patients after implantation of continuous and pulsatile flow LVADs. J Heart Lung Transplant (2001) 1.45
Facts, at last, on management of small infrarenal aortic aneurysms. Lancet (1998) 1.39
Modified approach to close multiple apical ventricular septal defects. Eur J Cardiothorac Surg (1999) 1.39
Reprinted article "Endovascular repair with bifurcated stent-grafts under local anaesthesia to improve outcome of ruptured aortoiliac aneurysms". Eur J Vasc Endovasc Surg (2011) 1.38
Reoperations after operation on the thoracic aorta: etiology, surgical techniques, and prevention. Ann Thorac Surg (1993) 1.29
Cryopreserved arterial homografts for in situ reconstruction of mycotic aneurysms and prosthetic graft infection. Eur J Cardiothorac Surg (1995) 1.27
Influence of three-dimensional vision on surgical telemanipulator performance. Surg Endosc (2001) 1.24
Internal mammary artery anomalies. Thorac Cardiovasc Surg (1990) 1.19
Cardiac valve surgery in the octogenarian. Heart (2000) 1.10
Pathologic anatomy of corrected transposition of the great arteries: medical and surgical implications. Am Heart J (1998) 1.09
Choice of revascularization strategy for patients with coronary artery disease. JAMA (2001) 1.08
Reoxygenation of hypoxic human umbilical vein endothelial cells activates the classic complement pathway. Circulation (1997) 1.07
New pulsatile bioreactor for in vitro formation of tissue engineered heart valves. Tissue Eng (2000) 1.06
Reduction and elimination of systemic heparinization during cardiopulmonary bypass. J Thorac Cardiovasc Surg (1992) 1.06
Drainage of the inferior vena cava to the left atrium. Ann Thorac Surg (1999) 1.05
Operative results of "repair" of ventricular septal rupture after acute myocardial infraction. Am J Cardiol (1999) 1.05
Aortobronchial and aortoesophageal fistulae as risk factors in surgery of descending thoracic aortic aneurysms. Eur J Cardiothorac Surg (1997) 1.01
The relevance of large strains in functional tissue engineering of heart valves. Thorac Cardiovasc Surg (2003) 0.99
HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins. J Am Coll Cardiol (2000) 0.99
Eradication of aortic infections with the use of cryopreserved arterial homografts. Ann Thorac Surg (1996) 0.98
Risk and benefit of low systemic heparinization during open heart operations. Ann Thorac Surg (1994) 0.98
Kartagener's syndrome: clinical presentation and cardiosurgical aspects. Ann Thorac Surg (1996) 0.97
Value of cardiac troponin I and T for selection of heart donors and as predictors of early graft failure. Transplantation (2001) 0.97
Endoscopic saphenous vein harvesting for CABG -- a randomized, prospective trial. Thorac Cardiovasc Surg (2002) 0.97
Multidrug-resistant gram-positive infections in patients with ventricular assist devices: the role of daptomycin. Transplant Proc (2009) 0.97
Experience with postinfarction left ventricular free wall rupture. Ann Thorac Surg (2000) 0.96
Explanted cryopreserved allografts: a morphological and immunohistochemical comparison between arterial allografts and allograft heart valves from infants and adults. Eur J Cardiothorac Surg (1999) 0.95
Interventional closure of two fistulas after aortic valve surgery. Clin Res Cardiol (2009) 0.93
Management of infected aortic grafts: development of less invasive surgery using cryopreserved homografts. Ann Thorac Surg (1999) 0.93
Ruptured abdominal aortic aneurysms: predictors for early complications and death. Surgery (1993) 0.92
Factors influencing the individual effects of blood transfusions on oxygen delivery and oxygen consumption. Crit Care Med (1999) 0.91
Modification of surgical aortoatrial shunts for inaccessible bleeding in aortic surgery -- modification of the Cabrol-shunt technique. Thorac Cardiovasc Surg (2001) 0.91
[Aortic valve insufficiency in Crohn disease]. Schweiz Med Wochenschr (1997) 0.91
Treatment of left atrial dissection after mitral repair: internal drainage. Ann Thorac Surg (1999) 0.91
Long-term follow-up in hypertrophic obstructive cardiomyopathy after septal myectomy. Ann Thorac Surg (1998) 0.90
Right coronary artery from aorto-left ventricular tunnel: case report of a new surgical approach. J Thorac Cardiovasc Surg (1998) 0.90
Clinical implications of phrenic nerve injury after pediatric cardiac surgery. J Pediatr Surg (1996) 0.89
In situ repair of aortobronchial, aortoesophageal, and aortoenteric fistulae with cryopreserved aortic homografts. J Vasc Surg (1997) 0.89
Design and fabrication of three-dimensional scaffolds for tissue engineering of human heart valves. Eur Surg Res (2008) 0.89
Complete thromboendarterectomy of the calcified ascending aorta and aortic arch. Ann Thorac Surg (1999) 0.88
Spacecraft bacterium, Paenibacillus pasadenensis, causing wound infection in humans. BMJ Case Rep (2010) 0.88
Sternal cleft associated with vascular anomalies and micrognathia. Ann Thorac Surg (1993) 0.88
Optimal cell source for cardiovascular tissue engineering: venous vs. aortic human myofibroblasts. Thorac Cardiovasc Surg (2001) 0.87
Reoperative surgery for degenerated aortic bioprostheses: predictors for emergency surgery and reoperative mortality. Eur J Cardiothorac Surg (2000) 0.87
A primary cardiac sarcoma with unusual histology and clinical course. Ann Thorac Surg (2001) 0.87
Left ventricular assist device as bridge to heart transplantation--lessons learned with the MicroMed DeBakey axial blood flow pump. Eur J Cardiothorac Surg (2003) 0.87
Genetic predisposition in patients undergoing cardiopulmonary bypass surgery is associated with an increase of inflammatory cytokines. Eur J Cardiothorac Surg (2001) 0.87
To compare general, epidural and local anaesthesia for endovascular aneurysm repair (EVAR). Eur J Vasc Endovasc Surg (2001) 0.87
Endovascular repair with bifurcated stent-grafts under local anaesthesia to improve outcome of ruptured aortoiliac aneurysms. Eur J Vasc Endovasc Surg (2002) 0.86
Endoscopic computer-enhanced beating heart coronary artery bypass grafting. Ann Thorac Surg (2000) 0.86
Surgical management of infected permanent transvenous pacemaker systems: ten year experience. J Card Surg (1997) 0.86
Regulation of matrix metalloproteinases and effect of MMP-inhibition in heart transplant related reperfusion injury. Eur J Cardiothorac Surg (2002) 0.86
Effect of anaesthesia and cardiopulmonary bypass on blood endocannabinoid concentrations during cardiac surgery. Br J Anaesth (2010) 0.85
Acute lung injury during cardiopulmonary bypass. Are the neutrophils responsible? Chest (1995) 0.85
Pneumonia after cardiac surgery is predictable by tracheal aspirates but cannot be prevented by prolonged antibiotic prophylaxis. Ann Thorac Surg (2001) 0.85
Cryopreserved arterial allografts in the treatment of major vascular infection: a comparison with conventional surgical techniques. J Thorac Cardiovasc Surg (1998) 0.85
Modified operation technique for orthotopic heart transplantation. Eur J Cardiothorac Surg (1995) 0.84
Use of methylene blue in the treatment of refractory vasodilatory shock after cardiac assist device implantation: report of four consecutive cases. J Clin Med Res (2012) 0.84
Preoperative administration of steroids: influence on adhesion molecules and cytokines after cardiopulmonary bypass. Ann Thorac Surg (2001) 0.84
Tricuspid valve obstruction caused by plasmacytoma metastasis. Ann Thorac Surg (1992) 0.84
Conservative treatment of the aortic root in acute type A dissection. Eur J Cardiothorac Surg (1999) 0.84
Modified ultrafiltration lowers adhesion molecule and cytokine levels after cardiopulmonary bypass without clinical relevance in adults. Eur J Cardiothorac Surg (2000) 0.84
Advanced training model for beating heart coronary artery surgery: the Zurich heart-trainer. Eur J Cardiothorac Surg (2002) 0.83
Operation for two-vessel coronary artery disease: midterm results of bilateral ITA grafting versus unilateral ITA and saphenous vein grafting. Ann Thorac Surg (1996) 0.83
Late-onset tacrolimus-associated cerebellar atrophia in a heart transplant recipient. J Heart Lung Transplant (2007) 0.83
Prevalence and persistence of heparin/platelet factor 4 antibodies in patients with heparin coated and noncoated ventricular assist devices. ASAIO J (2000) 0.82
Use of glue to avoid formation of perfused recesses in aortic allograft implantation. Ann Thorac Surg (1994) 0.82
Relief of bronchial compression caused by a congenital heart defect by remodeling of the aortic arch. J Thorac Cardiovasc Surg (2000) 0.82
Tissue endothelin-converting enzyme activity correlates with cardiovascular risk factors in coronary artery disease. Circulation (2000) 0.82
Emergency surgery for acute infective aortic valve endocarditis: performance of cryopreserved homografts and mode of failure. Eur J Cardiothorac Surg (1997) 0.82
Expression of adhesion molecules and cytokines after coronary artery bypass grafting during normothermic and hypothermic cardiac arrest. Eur J Cardiothorac Surg (2000) 0.81
Surgical repair of postinfarction structural failure of the posterobasal part of the heart. Ann Thorac Surg (1999) 0.81
Continuous blood pressure monitoring utilizing a CMOS tactile sensor. Conf Proc IEEE Eng Med Biol Soc (2004) 0.81
Frequency of collateral blood flow in the infarct-related coronary artery in rupture of the ventricular septum after acute myocardial infarction. Am J Cardiol (2000) 0.81
Tissue engineering in cardiovascular surgery: new approach to develop completely human autologous tissue. Eur J Cardiothorac Surg (2000) 0.81
Superior late patency of small-diameter Dacron grafts seeded with omental microvascular cells: an experimental study. Ann Thorac Surg (1994) 0.81
Cardiac surgery in a high-risk group of patients: is prolonged postoperative antibiotic prophylaxis effective? J Thorac Cardiovasc Surg (1997) 0.81
Intractable ventricular tachycardia and bridging to heart transplantation with a non-pulsatile flow assist device in a patient with isolated left-ventricular non-compaction. J Heart Lung Transplant (2004) 0.81